The Fellow on Call: The Heme/Onc Podcast cover image

Episode 143: Myeloma Series, Pt. 4 - Myeloma Pharmacology (2025)

The Fellow on Call: The Heme/Onc Podcast

00:00

Daratumumab: Mechanism and Subcutaneous Use

Kathryn reviews CD38 targeting, immune effects, IV vs subcutaneous administration, and reduced reactions sub-Q.

Play episode from 30:35
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app